Population Health Partners

Founded -

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$176M
Portfolio companies 3
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
  • Life Science
  • Medical Device

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Population Health Partners:
Typical Co-investors
Population Health Partners is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Population Health Partners:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States, San Francisco
Funds with similar focus located in United States, San Francisco:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Ideaspring Capital India, Bangalore
Great Spirit Ventures United States, Mill Valley
Gryffindor Capital United States, Chicago
BrownSavano Direct Capital Partners United States, Baltimore
GADS Option Fund United States, Irvine
M-Invest Germany, Thuringen
For it Japan, Chiyoda
Jinfeng Investment China, Shanghai
Galvanize United States, Denver
Starship Ventures United States, San Francisco

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Fractyl Laboratories

Biotechnology
Health Care
Medical Device
Wellness
1
$100M16 Jun 2021 United States, " United States"}

Adagio Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
1
$336M19 Apr 2021 United States, " United States"}

Biotechnology
Life Science
Pharmaceutical
1
$188M14 Jan 2021 Netherlands, " The Netherlands"}

Adagio Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
1
$80M10 Nov 2020 United States, " United States"}
News
Carlyle and Leading Healthcare-Focused Venture Funds Announce Strategic Growth Investment of up to $430 Million in Saama

– Saama technologies announced a strategic growth investment and will be acquired by Carlyle.
– Saama’s intelligent Life Science Analytics Cloud (LSAC) is used by over 50 pharma and biotech companies on more than 1,500 studies.
– As an end-to-end platform, LSAC provides a unified approach to clinical trial data management and analytics.
– Carlyle has made a strategic growth investment and will acquire a majority stake in the Company.
– A broad co-investor group with several healthcare-focused venture funds, including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund, McKesson Ventures, Northpond Ventures, Pfizer Ventures, and Population Health Partners, will be investing alongside Carlyle.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Population Health Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: